Back to search

Article

Calciphylaxis as a Rare Complication Associated with Pemigatinib Treatment—A Case Report

2026-03-19

Abstract excerpt

Fibroblast growth factor receptor 2 (FGFR2) inhibitors such as pemigatinib are targeted therapies for cholangiocarcinoma with FGFR2 alterations. While generally well tolerated, they are associated with unique adverse events. Calciphylaxis, a potentially fatal vascular calcification disorder, is a rare complication. We present a 43-year-old woman with metastatic intrahepatic cholangiocarcinoma harboring an FGFR2 fu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
549e023d-e256-565f-af8e-eee99cd9f414
DOI
10.20944/preprints202603.1562.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Calciphylaxis as a Rare Complication Associated with Pemigatinib Treatment—A Case ReportDOI 10.20944/preprints202603.1562.v1
Select a neighboring publication to make it the new centre.